Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for ICLR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 -107.86M
March 31, 2026 -39.44M
December 31, 2025 -55.75M
September 30, 2025 -59.31M
June 30, 2025 -41.06M
March 31, 2025 -37.28M
December 31, 2024 -63.05M
September 30, 2024 -126.77M
June 30, 2024 -33.91M
March 31, 2024 -39.36M
December 31, 2023 -120.61M
September 30, 2023 -35.70M
June 30, 2023 -41.10M
March 31, 2023 -28.04M
December 31, 2022 -59.62M
September 30, 2022 -34.57M
June 30, 2022 -27.85M
March 31, 2022 -19.54M
December 31, 2021 43.56M
September 30, 2021 -5.843B
June 30, 2021 -16.58M
March 31, 2021 -9.303M
December 31, 2020 -70.62M
September 30, 2020 -12.30M
June 30, 2020 -10.97M
Date Value
March 31, 2020 -0.758M
December 31, 2019 -29.39M
September 30, 2019 -36.58M
June 30, 2019 -43.74M
March 31, 2019 -50.56M
December 31, 2018 -19.45M
September 30, 2018 7.763M
June 30, 2018 -10.53M
March 31, 2018 -13.86M
December 31, 2017 -12.65M
September 30, 2017 -139.26M
June 30, 2017 -12.10M
March 31, 2017 -21.60M
December 31, 2016 6.192M
September 30, 2016 -62.04M
June 30, 2016 -9.436M
March 31, 2016 -7.598M
December 31, 2015 -78.62M
September 30, 2015 -8.814M
June 30, 2015 -1.83M
March 31, 2015 -112.85M
December 31, 2014 -9.031M
September 30, 2014 -10.79M
June 30, 2014 -91.33M
March 31, 2014 5.379M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
IQVIA Holdings, Inc. -381.00M
Medpace Holdings, Inc. -23.88M
Proteome Sciences Plc --
Champions Oncology, Inc. -0.238M
Avantor, Inc. -37.30M